ArriVent BioPharma, Inc.
Pharmaceutical company · Newtown Square, Pennsylvania, United States · Nasdaq: AVBP
ArriVent BioPharma, Inc. is a pharmaceutical company headquartered in Newtown Square, Pennsylvania, United States. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker AVBP. It has reported private securities offerings to the US SEC, most recently $110 million sold in a notice filed in 2022.
ArriVent BioPharma at a glance
What does ArriVent BioPharma do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $110 million sold (2022).
Frequently asked questions about ArriVent BioPharma
Where is ArriVent BioPharma headquartered?
ArriVent BioPharma, Inc. is headquartered in Newtown Square, Pennsylvania, United States.
What does ArriVent BioPharma do?
ArriVent BioPharma, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is ArriVent BioPharma a public company?
Yes. ArriVent BioPharma, Inc. trades on Nasdaq under the ticker AVBP.
When was ArriVent BioPharma founded?
The earliest incorporation on record for ArriVent BioPharma, Inc. is in 2021, according to public company registers.
Similar companies
- Traws Pharma, Inc.Newtown, Pennsylvania, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.